This year, OSI awarded more than $1.5 million to help advance new treatments for osteosarcoma.
Stories of Progress, Inspiration & Support
Featured
With $15 million in funding, OSI and the broader osteosarcoma community, pediatric cancer foundations, and Break Through Cancer (BTC) have teamed up to bring BTC’s team-based approach to osteosarcoma, bringing together investigators from across the country and around the world.
The U.S. Food and Drug Administration (FDA), the Osteosarcoma Institute (OSI), and others are coming together to shape the future of osteosarcoma clinical trials.
Optimism surrounds osteosarcoma research as the OSI awards $1.1 million in cancer research funding to three innovative projects.
Award-winning researcher explains how his work seeks to better understand osteosarcoma’s genomic instability to uncover novel treatments for the most aggressive types of the disease.
After Vicki Bunke lost her 14-year-old daughter, Grace, to osteosarcoma, she started swimming across America to honor her legacy.
No results found.
Sign Up to Receive The Frontline
at vero eos et accusamus et iusto odio dignis simos duccimus qui blanditis
We never sell or share your information.
Your donation provides immediate and long-term support to osteosarcoma patients.